Oral Session 2-11B AML: Clinical Study (2)

[OS2-11B-4] Clinical features and prognostic impact of AML with the cohesin complex genes mutations

Marika Kuboyama¹, Kenta Date¹, Masahiro Sakaguchi¹, Toshimitsu Ueki², Kensuke Usuki³, Yutaka Kobayashi⁴, Kenji Tajika⁵, Seiji Gomi⁵, Saiko Kurosawa⁶, Taichiro Tokura¹, Kazuki Inai¹, Daishi Onai¹, Atsushi Marumo¹, Ikuko Omori¹, Satoshi Yamanaka¹, Yusuke Fujiwara¹, Shunsuke Yui¹, Satoshi Wakita¹, Muneo Okamoto¹, Miho Miyata¹, Kunihito Arai¹, Tomoaki Kitano¹, Kazuki Terada¹, Takahiro Fukuda⁶, Hiroki Yamaguchi¹, Koichi Inokuchi¹ (1.Department of Hematology, Nippon Medical School, Tokyo, Japan, 2.Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan, 3.Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan, 4.Hematology Division, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan, 5.Department of Hematology, Yokohama Minami Kyousai Hospital, Kanagawa, Japan, 6.Department of HSCT, National Cancer Center Hospital, Tokyo, Japan)